Infant Mortality due to Congenital Diaphragmatic Hernia, United States 2007-2021

Ramesh Vidavalur1,2, Kanekal S Gautham3

  • 1Division of Neonatology, Cayuga Medical Center, Ithaca, New York, USA.

Birth Defects Research
|November 12, 2025
PubMed

Insights

Infant mortality from congenital diaphragmatic hernia (CDH) is decreasing nationally, but significant geographic and demographic disparities persist. Further efforts are needed to ensure equitable outcomes for all infants with CDH.

Area of Science:

  • Pediatric Health
  • Public Health Surveillance
  • Neonatal Outcomes

Background:

  • Congenital diaphragmatic hernia (CDH) is a serious birth defect impacting infant survival.
  • Understanding temporal and geographic trends in CDH-related infant mortality is crucial for public health interventions.

Purpose of the Study:

  • To analyze temporal trends and geographic variations in the infant mortality rate associated with congenital diaphragmatic hernia (CDH-IMR) in the United States.
  • To identify demographic factors influencing CDH-IMR and explore regional disparities.

Main Methods:

  • Utilized CDC-WONDER linked birth/death data from 2007-2021 to identify CDH-related infant deaths (ICD-10: Q79).
  • Analyzed annual CDH-IMR trends using joinpoint regression and explored associations with sex, gender, gestational age (GA), and U.S. state of birth.
  • Calculated CDH-IMR per 100,000 live births and conducted bivariate analyses for demographic and regional comparisons.

Main Results:

  • A total of 3391 CDH-related infant deaths were recorded among over 59 million live births between 2007 and 2021.
  • The overall CDH-IMR showed a significant downward trend (APC: -1.3%).
  • Significant variations in CDH-IMR were observed across U.S. states (three-fold range), with lower mortality risk noted in Asian infants and improved survival associated with higher GA.

Conclusions:

  • A decreasing trend in congenital diaphragmatic hernia infant mortality rate (CDH-IMR) was observed in the U.S.
  • Despite the overall decline, significant disparities in CDH mortality persist based on region, gender, and race.
  • Equitable improvements in care are needed to address variations in outcomes across different demographic groups and geographic locations.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
2.5K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
3.0K